Finance Home - My Yahoo - Yahoo! - Help

Friday, July 10, 2009, 4:14AM ET - U.S. Markets open in 5 hours and 16 minutes. Dow  0.06% Nasdaq  0.00%

Salix Pharmaceuticals Ltd. (SLXP)

On Jul 9: 9.73   0.00 (0.00%)

MORE ON SLXP

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Jul 7, 2009 • Coverage initiated on Salix Pharm by Piper Jaffray Briefing.com (Tue, Jul 7) Mon, Jun 22, 2009 • Pending FDA Decisions: 20 Extreme Trades at Seeking Alpha (Mon, Jun 22) Mon, Jun 15, 2009 • Salix rises after analyst upgrades on Xifaxan AP (Mon, Jun 15) Thu, Jun 11, 2009 • SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online (Thu, Jun 11) Wed, Jun 10, 2009 • Nausea drug safe for fetus - study at Reuters (Wed, Jun 10) Tue, Jun 2, 2009 • SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Jun 2) • Salix's Once-Daily APRISO Demonstrates Long-Term Safety in Patients for Maintenance of Remission From Ulcerative Colitis Marketwire (Tue, Jun 2) • Salix's Once-Daily APRISO Demonstrates Long-Term Safety in Patients for Maintenance of Remission from Ulcerative Colitis Business Wire (Tue, Jun 2) • Salix's Once-Daily APRISO Demonstrates Long-Term Safety in Patients for Maintenance of Remission From Ulcerative Colitis Marketwire (Tue, Jun 2) Mon, Jun 1, 2009 • SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Mon, Jun 1) • Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week (DDW) Business Wire (Mon, Jun 1) Wed, May 13, 2009 • Salix Pharmaceuticals (SLXP) Zacks.com (Wed, May 13) Tue, May 12, 2009 • SunPower Corp., Salix Pharmaceuticals, Acadia Pharmaceuticals, Biovail, Allergan Zacks.com (Tue, May 12) • SALIX PHARMACEUTICALS LTD Financials EDGAR Online Financials (Tue, May 12) Mon, May 11, 2009 • SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Mon, May 11) • Certain Salix Officers and Directors Adopt 10b5-1 Trading Plans for Stock Options that are Scheduled to Expire During 2010 Business Wire (Mon, May 11) Wed, May 6, 2009 • SALIX PHARMACEUTICALS LTD Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, May 6) Tue, May 5, 2009 • Salix Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN (Tue, May 5) • SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial EDGAR Online (Tue, May 5) • Salix Pharmaceuticals Reports 1Q2009 Results Business Wire (Tue, May 5) Older Headlines - Download Recent Headlines View headlines from: Tue, May 5, 2009Tue, Apr 28, 2009Tue, Apr 21, 2009Tue, Apr 14, 2009Tue, Apr 7, 2009Tue, Mar 31, 2009Tue, Mar 24, 2009Tue, Mar 17, 2009Tue, Mar 10, 2009Tue, Mar 3, 2009 Add SLXP News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage